XML 74 R38.htm IDEA: XBRL DOCUMENT v3.19.2

Earnings per Share (Tables)

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Basic and diluted earnings per share

Basic and diluted earnings per share are calculated as follows:

	For the Three Months Ended June 30,								For the Six Months Ended June 30,
(In millions)	2019				2018				2019				2018
Numerator:
Net income attributable to Biogen Inc.	$	1,494.1			$	866.6			$	2,902.9			$	2,039.5
Denominator:
Weighted average number of common shares outstanding	190.3				207.1				193.4				209.2
Effect of dilutive securities:
Stock options and employee stock purchase plan	—				—				—				—
Time-vested restricted stock units	0.1				0.1				0.2				0.2
Market stock units	—				0.1				0.1				0.1
Performance stock units settled in stock	—				—				—				—
Dilutive potential common shares	0.1				0.2				0.3				0.3
Shares used in calculating diluted earnings per share	190.4				207.3				193.7				209.5

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration